M E Brandt

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Chemother 15:36-47. 2003
  2. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 45:3065-9. 2001
  3. pmc Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
    M E Brandt
    Emerging Bacterial and Mycotic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 34:912-7. 1996
  4. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
  5. pmc Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR
    C Muñoz-Cadavid
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 48:2147-53. 2010
  6. pmc Candida dubliniensis fungemia: the first four cases in North America
    M E Brandt
    Centers for Disease Control and Prevention CDC Atlanta, Georgia, USA
    Emerg Infect Dis 6:46-9. 2000
  7. pmc Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature
    C T Sacchi
    Division of Medical Biology, Bacteriology Department, Adolfo Lutz Institute, Sao Paulo, Brazil
    Clin Diagn Lab Immunol 5:845-55. 1998
  8. pmc Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system
    C T Sacchi
    Bacteriology Division, Adolfo Lutz Institute, Sao Paulo, Brazil
    Clin Diagn Lab Immunol 5:348-54. 1998
  9. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
  10. pmc Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus
    M E Brandt
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 36:2057-62. 1998

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Chemother 15:36-47. 2003
    ..The development of new antifungal agents and combination treatment may help to improve the management of these infections...
  2. pmc Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998
    M E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Antimicrob Agents Chemother 45:3065-9. 2001
    ..We conclude that in vitro resistance to antifungal agents remains uncommon in C. neoformans and has not significantly changed with time during the past decade...
  3. pmc Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group
    M E Brandt
    Emerging Bacterial and Mycotic Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 34:912-7. 1996
    ..neoformans possesses a clonal population structure. Continued application of molecular subtyping methods will be useful in tracking the source, transmission, and relative virulence of different C. neoformans strains...
  4. ncbi request reprint Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group
    R A Hajjeh
    Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
    J Infect Dis 179:449-54. 1999
    ..Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy...
  5. pmc Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR
    C Muñoz-Cadavid
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 48:2147-53. 2010
    ..Factors such as sensitivity, cost, and labor will help guide the selection of the most appropriate method for the needs of each laboratory...
  6. pmc Candida dubliniensis fungemia: the first four cases in North America
    M E Brandt
    Centers for Disease Control and Prevention CDC Atlanta, Georgia, USA
    Emerg Infect Dis 6:46-9. 2000
    ..All isolates were susceptible in vitro to commonly used antifungal drugs. This report demonstrates that C. dubliniensis can cause bloodstream infection; however, the incidence of disease is not known...
  7. pmc Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature
    C T Sacchi
    Division of Medical Biology, Bacteriology Department, Adolfo Lutz Institute, Sao Paulo, Brazil
    Clin Diagn Lab Immunol 5:845-55. 1998
    ..This scheme will be useful in future classification and applied epidemiologic studies of N. meningitidis, being a systematic way of selecting PorA vaccine candidates and analyzing vaccine coverage and failure...
  8. pmc Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system
    C T Sacchi
    Bacteriology Division, Adolfo Lutz Institute, Sao Paulo, Brazil
    Clin Diagn Lab Immunol 5:348-54. 1998
    ..The present work represents the most complete and integrated data set of PorB VR sequences and MAb reactivities of serogroup B and C meningococci produced to date...
  9. ncbi request reprint Candidemia in pediatric outpatients receiving home total parenteral nutrition
    M V Cano
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Med Mycol 43:219-25. 2005
    ..Our findings underscore the challenges of maintaining stringent infection control practices in the home health care setting and suggest the need for more intensive follow-up and coordination of home TPN therapy among pediatric patients...
  10. pmc Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus
    M E Brandt
    Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 36:2057-62. 1998
    ..This RAPD-PCR and TaqMan assay offers promise as a nucleic acid-based system that can be used for the identification of filamentous fungal isolates and that requires no postamplification sample manipulations...
  11. ncbi request reprint Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru
    G M Lyon
    Epidemic Intelligence Service, Epidemiology Program Office, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 36:34-9. 2003
    ..Decreased environmental exposure, such wearing protective clothing during construction activities for adults or limiting contact with cats and soil for children, and improvements in living spaces may decrease the incidence of LS...
  12. pmc Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes
    T D Ferguson
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    J Clin Microbiol 45:1648-51. 2007
    ..The causative agent was identified as Apophysomyces elegans, an emerging cause of zygomycosis in immunocompetent hosts...
  13. pmc Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum
    L M Weigel
    Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235
    Infect Immun 60:1568-76. 1992
    ....